Head-to-head · WeighScore
Go Vida Plena vs Strut Health
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 68.2/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Before you choose
Before comparing the headline prices, the Go Vida Plena review and the Strut Health review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Go Vida Plena vs TelePeptide and HealthHub vs Strut Health compare each of them with another graded program, and the list of alternatives to Go Vida Plena ranks the programs closest to Go Vida Plena on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Go Vida Plena | Strut Health |
|---|---|---|
| WeighScore | 68.2/100 | 79.4/100 |
| Grade | C | C+ |
| Site position | #165 | #26 |
| Semaglutide | Advertised shortest-plan payment $269 injectable or $299 oral; confirm quote | Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal |
| Tirzepatide | Advertised shortest-plan payment $359 injectable or $349 oral; confirm quote | Oral $199/30 days; injection from $149/mo depending on prescribed dose—confirm quantity and renewal |
| Coverage | Confirm treatment availability in your state | FAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes separate oral and injectable plan totals
- Policy says plans do not automatically renew
- Advertises nutrition support and clinician follow-up
What to consider
- Unused prepaid time is generally not prorated or refunded
- Selected treatment and charge depend on eligibility and the plan
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
- Provider consultations, follow-ups and shipping are advertised as included
- Current help describes an account cancellation button; terms also provide an email route
- Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription
What to consider
- Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
- Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
- 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
- Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Featured provider
Strut Health
Factor scores not reassessed.Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.